SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-013296
Filing Date
2023-02-21
Accepted
2023-02-21 16:15:37
Documents
3
Period of Report
2023-02-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea173983-6k_nlspharma.htm 6-K 14328
2 AMENDED AND RESTATED ARTICLES OF ASSOCIATION ea173983ex99-1_nlspharma.htm EX-99.1 252829
3 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF ASSOCIATION ea173983ex99-2_nlspharma.htm EX-99.2 246245
  Complete submission text file 0001213900-23-013296.txt   514396
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 23648298
SIC: 2834 Pharmaceutical Preparations